Institute For Clinical Evaluative Sciences

Rediff.com » News » Institute For Clinical Evaluative Sciences

News for Institute For Clinical Evaluative Sciences

News
Business

Zodiac signs & disorders are linked: survey

People born under the zodiac sign Virgo vomit more during pregnancy, Pisces have greater risk of heart failure, while Libras have an increased risk of fracturing their pelvises. Each of the 12......

Covaxin emergency use decision likely in 4-6 weeks: WHO

The World Health Organization is likely to take a decision on including Bharat Biotech's COVID-19 vaccine Covaxin in the emergency use list (EUL) within four to six weeks, Soumya Swaminathan, the......

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said. IMAGE: Kindly......

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and......

Recruitment for trial of Covaxin in 6-12 age group to start from Tuesday

The recruitment for the clinical trial of the country's first indigenously-developed COVID-19 vaccine, Covaxin, among children in the age group of 6-12 years will begin at the AIIMS in New Delhi......

AstraZeneca plans R&D tie-ups with Indian firms

US-based pharmaceutical and research giant AstraZeneca is planning to collaborate with two research-based Indian pharma companies.The company had earlier signed a research collaboration agreement......

Innovative field research in India helped Abhijit Banerjee and Esther Duflo win Economics Nobel

This year's Laureates have shown how the problem of global poverty can be tackled by breaking it down into a number of smaller - but more precise - questions at individual or group levels, he Royal......

Nicholas Piramal develops novel anti-cancer drug

Pharma major Nicholas Piramal India Ltd has claimed to have developed a novel anti-cancer drug to arrest and regulate the multiplication of cancer cells.Described as an important therapeutic......

Indian innovation patented in US

In a development marking the global market potential of Indian grassroots innovations, a foot-pedal sprayer pump has been patented in the United States and its technology transferred to a US......

Pharma majors open new R&D chapter

USV, a Mumbai-based Rs 800 crore drug manufacturer with research expertise in small molecules and proteins, recently decided to venture into the lucrative segment of vaccines. For that, it decided......

Rediff News

Institute For Clinical Evaluative Sciences

News for Institute For Clinical Evaluative Sciences

Zodiac signs & disorders are linked: survey

Covaxin emergency use decision likely in 4-6 weeks: WHO

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Recruitment for trial of Covaxin in 6-12 age group to start from Tuesday

AstraZeneca plans R&D tie-ups with Indian firms

Innovative field research in India helped Abhijit Banerjee and Esther Duflo win Economics Nobel

Nicholas Piramal develops novel anti-cancer drug

Indian innovation patented in US

Pharma majors open new R&D chapter

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS